1. Home
  2. PFE vs SNPS Comparison

PFE vs SNPS Comparison

Compare PFE & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFE
  • SNPS
  • Stock Information
  • Founded
  • PFE 1849
  • SNPS 1986
  • Country
  • PFE United States
  • SNPS United States
  • Employees
  • PFE N/A
  • SNPS 20000
  • Industry
  • PFE Biotechnology: Pharmaceutical Preparations
  • SNPS EDP Services
  • Sector
  • PFE Health Care
  • SNPS Technology
  • Exchange
  • PFE Nasdaq
  • SNPS Nasdaq
  • Market Cap
  • PFE 134.2B
  • SNPS 115.8B
  • IPO Year
  • PFE N/A
  • SNPS 1992
  • Fundamental
  • Price
  • PFE $24.45
  • SNPS $619.47
  • Analyst Decision
  • PFE Hold
  • SNPS Strong Buy
  • Analyst Count
  • PFE 13
  • SNPS 15
  • Target Price
  • PFE $29.75
  • SNPS $615.33
  • AVG Volume (30 Days)
  • PFE 46.5M
  • SNPS 2.5M
  • Earning Date
  • PFE 08-05-2025
  • SNPS 09-09-2025
  • Dividend Yield
  • PFE 7.10%
  • SNPS N/A
  • EPS Growth
  • PFE N/A
  • SNPS 51.03
  • EPS
  • PFE 1.89
  • SNPS 13.85
  • Revenue
  • PFE $63,833,000,000.00
  • SNPS $6,221,316,000.00
  • Revenue This Year
  • PFE N/A
  • SNPS $13.59
  • Revenue Next Year
  • PFE N/A
  • SNPS $15.32
  • P/E Ratio
  • PFE $12.79
  • SNPS $44.77
  • Revenue Growth
  • PFE 13.53
  • SNPS 7.50
  • 52 Week Low
  • PFE $20.92
  • SNPS $365.74
  • 52 Week High
  • PFE $30.43
  • SNPS $651.73
  • Technical
  • Relative Strength Index (RSI)
  • PFE 50.21
  • SNPS 61.41
  • Support Level
  • PFE $23.86
  • SNPS $608.19
  • Resistance Level
  • PFE $24.89
  • SNPS $632.99
  • Average True Range (ATR)
  • PFE 0.49
  • SNPS 17.87
  • MACD
  • PFE -0.04
  • SNPS -3.02
  • Stochastic Oscillator
  • PFE 52.74
  • SNPS 58.87

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: